AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 274: G955-G964, 1998;
0193-1857/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehrlich, K.
Right arrow Articles by Peskar, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehrlich, K.
Right arrow Articles by Peskar, B. M.
Vol. 274, Issue 5, G955-G964, May 1998

Peptidergic and cholinergic neurons and mediators in peptone-induced gastroprotection: role of cyclooxygenase-2

Karlheinz Ehrlich1, Susanne Plate1, Thomas Stroff1, Britta Gretzer1, Michael Respondek2, and Brigitta M. Peskar1

Departments of 1 Experimental Clinical Medicine and 2 Pathology, Ruhr-University of Bochum, D-44780 Bochum, Germany

This study investigates the neural pathways, mediators, and cyclooxygenase isoenzymes involved in the gastroprotection conferred by peptone in rats. Intragastric perfusion with 8% peptone protected against gross and histological damage induced by subsequent perfusion with 50% ethanol. The gastroprotective effect of peptone was near maximally inhibited by gastrin immunoneutralization, inactivation of capsaicin-sensitive afferent neurons, calcitonin gene-related peptide (CGRP) immunoneutralization, blockade of gastrin receptors, CGRP, bombesin/gastrin-releasing peptide (GRP), or somatostatin receptors, and by the nitric oxide (NO) synthase inhibitor NG-nitro-L-arginine methyl ester and was partially (46%) counteracted by atropine. Indomethacin and the selective cyclooxygenase-2 inhibitors NS-398 and L-745,337 dose dependently (50% inhibitory dose, 4.2, 0.8, and 1.5 mg/kg, respectively) attenuated the peptone-induced protection. Dexamethasone was ineffective. These results indicate that protective effects of peptone involve endogenous gastrin and possibly somatostatin and are mediated by capsaicin-sensitive afferent, cholinergic, and bombesin/GRP neurons. CGRP, NO, and prostaglandins participate as essential mediators. The study provides evidence that prostaglandins derived from a constitutive cyclooxygenase-2 contribute to mucosal defense in the presence of ulcerogens and thus participate in homeostatic functions of the stomach.

afferent neurons; nitric oxide; calcitonin gene-related peptide; somatostatin


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Komori, S. Tsuji, W.-H. Sun, M. Tsujii, N. Kawai, M. Yasumaru, Y. Kakiuchi, A. Kimura, Y. Sasaki, S. Higashiyama, et al.
Gastrin enhances gastric mucosal integrity through cyclooxygenase-2 upregulation in rats
Am J Physiol Gastrointest Liver Physiol, December 1, 2002; 283(6): G1368 - G1378.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
F HALTER, A S TARNAWSKI, A SCHMASSMANN, and B M PESKAR
Cyclooxygenase 2{---}implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives
Gut, September 1, 2001; 49(3): 443 - 453.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. Yang, K. Kawakubo, and Y. Tache
Intracisternal PYY increases gastric mucosal resistance: role of cholinergic, CGRP, and NO pathways
Am J Physiol Gastrointest Liver Physiol, September 1, 1999; 277(3): G555 - G562.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online